DOTA Conjugated JM21 derivative 7, CAS [[3033865-40-3]] Preis auf Anfrage

Catalog Number: MCE-HY-P10444
Article Name: DOTA Conjugated JM21 derivative 7, CAS [[3033865-40-3]] Preis auf Anfrage
Biozol Catalog Number: MCE-HY-P10444
Supplier Catalog Number: HY-P10444
Alternative Catalog Number: MCE-HY-P10444-1UNIT
Manufacturer: MedchemExpress
Category: Proteine/Peptide
DOTA Conjugated JM21 derivative 7 (compound Ligand-7) is a derivative of CXCR4 targeting peptide conjugated with DOTA and can be used to produce radioligands. Radiolabeled DOTA Conjugated JM21 derivative 7, i.e., 177Lu-DOTA, has excellent CXCR4 tumor t
Molecular Weight: 1471.75
CAS Number: [3033865-40-3]
Formula: C66H114N22O16
Target: CXCR,Radionuclide-Drug Conjugates (RDCs)
Application Notes: Peptides